TrialBritish journal of cancer2004

A phase I trial of DNA vaccination with a plasmid expressing prostate-specific antigen in patients with hormone-refractory prostate cancer.

M Pavlenko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.